Insider Trading & Executive Data
Start Free Trial
86 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Aeva Technologies develops a proprietary Frequency Modulated Continuous Wave (FMCW) 4D LiDAR‑on‑chip platform (products: Aeries II, Atlas, Atlas Ultra) that measures range, reflectivity and instantaneous velocity per pixel for long‑range automotive and industrial sensing applications. Target markets include automotive ADAS/autonomy (passenger cars, trucking, new mobility), industrial automation, consumer devices and security; revenue to date has been driven largely by prototype sales, strategic partnerships and non‑recurring engineering (NRE) engagements rather than production program revenue. The company outsources manufacturing while keeping R&D and product engineering in‑house (U.S. and India), holds a growing IP estate (~245 issued patents, ~155 pending), and faces long OEM/Tier‑1 design‑in cycles, supply‑chain dependencies and regulatory/legal contingencies (including a $14M settlement accrual). Recent results show rapid prototype revenue growth (2024 revenue +110% to $9.1M; Q2 2025 revenue +174% YoY) but continued sizable operating losses and liquidity reliance on a $125M standby equity facility.
Expect compensation to be heavily equity‑centric and retention‑focused: the filings already show increases in stock‑based compensation and payroll, reflecting competition for specialized optics/ASIC/R&D talent and the need to retain engineers through multi‑year design‑in cycles. Pay plans are likely to mix time‑vested RSUs/options with milestone or performance‑based awards tied to measurable commercialization events (design wins, program transitions to production, per‑unit pricing/margins), NRE/order bookings and cost‑control metrics given volatile gross margins and production cost sensitivity. Short‑term cash incentives (if any) will likely emphasize program milestones and delivery metrics rather than revenue run‑rate, while long‑term incentives hinge on successful OEM qualification and scale production; governance may include standard change‑in‑control protections and retention stipends to limit turnover during lengthy validation phases. Litigation accruals, accounting remeasurements (warrants/share liabilities) and liquidity pressures can also affect valuation assumptions for awards and prompt use of more conservative severance/clawback language.
Insider activity should be interpreted in the context of development milestones and financing events: purchases following announced design‑wins, production launches or strategic customer commitments are higher‑conviction signals, while sales clustered around financing draws (the Sylebra standby facility, the LGIT private placement) or prior to announced dilutive financings can reflect liquidity or tax‑related exercises rather than confidence. Watch for predictable selling tied to option/RSU vesting or to cover taxes, and for use of 10b5‑1 plans which are common in equity‑heavy, cash‑constrained tech firms; insiders are also subject to Section 16 reporting and typical blackout windows around earnings, customer announcements, and material regulatory filings. Given material non‑cash fair‑value swings (warrant and subscription liability remeasurements) and ongoing legal/regulatory risks (NHTSA, FDA laser rules, environmental permits), short‑term insider trades close to these disclosures merit extra scrutiny.